CLINICAL_TRIALS ClinicalTrials.gov record update

Rapamycin-Resistant T Cell Therapy of Multiple Myeloma: Relapse Prevention and Relapse Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01239368
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:28.919555+00:00
Published At: 2018-10-16T00:00:00+00:00
Record Updated At: 2019-12-10
Results Posted At: 2018-10-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myeloma, Plasma-Cell", "Myeloma-Multiple", "Myelomatosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-12-10"
protocolSection.identificationModule.nctId: "NCT01239368"
protocolSection.identificationModule.officialTitle: "Rapamycin-Resistant T Cell Therapy of Multiple Myeloma: Relapse Prevention and Relapse Therapy"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-10-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.